Inventor
MINGWEI ZHENG
Inventor
CN
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
C07CAcyclic or carbocyclic compounds7%
LOC277%
PatentTitleYear
D1080988Smoking cessation device202512,291,518Thyroid hormone receptor agonists and use thereof202512,234,232Aromatic heterocyclic compound with kinase inhibitory activity202511,787,766Compound having PD-L1 inhibitory activity, preparation method therefor and use thereof202311,780,825Thyroid hormone receptor agonists and use thereof2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to SHANGHAI ENNOVABIO PHARMACEUTICALS CO LTD (2)· patent assignee history
2023Patents assigned to ECCOGENE SHANGHAI CO LTD (1)· patent assignee history
2023–2025Based in CN· patent location history
2025Patents assigned to ECCOGENE INC (1)· patent assignee history
2025Patents assigned to ZHENG MINGWEI (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SHANGHAI ENNOVABIO PHARMACEUTICALS CO LTD | 2 | 2023–2025 |
| ECCOGENE INC | 1 | 2025 |
| ECCOGENE SHANGHAI CO LTD | 1 | 2023 |
| ZHENG MINGWEIself | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 5 | 2023–2025 |